Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /
The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Yhteisötekijä: | |
| Aineistotyyppi: | Elektroninen E-kirja |
| Kieli: | English |
| Julkaistu: |
Heidelberg :
Physica-Verlag HD : Imprint: Physica,
2006.
|
| Painos: | 1st ed. 2006. |
| Sarja: | Contributions to Management Science,
|
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/3-7908-1668-X |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|